Valuation: IOL Chemicals and Pharmaceuticals Limited

Market Cap 58.96B 609M 544M 506M 460M 869M 873M 6.09B 2.39B 30.06B 2.29B 2.24B 96.46B P/E 2027 *
26.8x
P/E 2028 * 19.3x
Enterprise Value 58.96B 609M 544M 506M 460M 869M 873M 6.09B 2.39B 30.06B 2.29B 2.24B 96.46B EV / Sales 2027 *
2.15x
EV / Sales 2028 * 1.82x
Free-Float
37.72%
Yield 2027 *
-
Yield 2028 * -

Last Transcript: IOL Chemicals and Pharmaceuticals Limited

1 day-2.36%
1 week-4.11%
Current month-3.06%
1 month-4.24%
3 months+19.52%
6 months+148.48%
Current year+144.19%
1 week 199.55
Extreme 199.55
224
1 month 173.6
Extreme 173.6
224
Current year 67.14
Extreme 67.14
224
1 year 67.14
Extreme 67.14
224
3 years 57.51
Extreme 57.51
224
5 years 54.44
Extreme 54.44
224
10 years 8.4
Extreme 8.4
224
Manager TitleAgeSince
Chief Executive Officer 34 -
Director of Finance/CFO - -
Compliance Officer - 13/11/2019
Director TitleAgeSince
Chairman 63 31/08/2007
Director/Board Member 34 28/05/2015
Chairman 73 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.36%-4.11%+100.65%+120.64% 609M
+0.83%+3.19%+37.87%+106.25% 1,051B
+1.93%+2.11%+36.82%+64.90% 630B
+1.49%+5.19%+19.84%+85.41% 489B
+2.26%+0.90%+66.40%+39.33% 359B
+1.45%+3.50%+21.87%+42.64% 344B
+1.17%+2.37%+11.71%+35.14% 272B
+0.89%+1.08%-7.28%+10.52% 246B
+1.82%+2.94%+40.43%+52.78% 224B
+2.77%+4.44%+29.49%+101.40% 187B
Average +1.11%+1.87%+35.78%+65.90% 380.43B
Weighted average by Cap. +1.20%+2.44%+31.58%+69.97%

Financials

2027 *2028 *
Net sales 27.42B 283M 253M 235M 214M 404M 406M 2.83B 1.11B 13.98B 1.06B 1.04B 44.87B 32.4B 335M 299M 278M 253M 478M 480M 3.35B 1.31B 16.52B 1.26B 1.23B 53.01B
Net income 2.2B 22.71M 20.28M 18.87M 17.16M 32.4M 32.55M 227M 88.98M 1.12B 85.28M 83.42M 3.6B 3.06B 31.62M 28.24M 26.27M 23.89M 45.11M 45.31M 316M 124M 1.56B 119M 116M 5.01B
Net Debt - -
Projected Income Statement - Annual - IOL Chemicals and Pharmaceuticals Limited
Logo IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) including Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Losartan Potassium, Levetiracetam, and Fenofibrate (Micronised). Its Specialty Chemical division includes Ethyl Acetate, Iso Butyl Benzene, Mono Chloro acetic Acid, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and the paint industry.
Employees
3,095
Date Price Change Volume
09/10/26 ₹200.85 -2.36% 229,349
08/10/26 ₹205.70 -6.67% 302,195
07/10/26 ₹220.40 +2.75% 431,954
06/10/26 ₹214.50 +4.33% 225,047
05/10/26 ₹205.60 -1.84% 232,864
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
200.85INR
Average target price
223.00INR
Spread / Average Target
+11.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IOL Chemicals and Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. IOLCP Stock